Argento Conference Room, pav. 18 - The session will be held in Italian
2.00pm - 3.10pm Orphan drugs for rare diseases

Chair: Leonardo Santi (National Committee for Biosafety and Biotechnology)
Massimo Boriero (Presidente Gruppo Biotecnolgie-Farmindustria)

Chairman's address

Malattie rare e farmaci orfani: a che punto siamo a livello europeo e nazionale?
Domenica Taruscio (Direttore del Centro Nazionale Malattie Rare Istituto Superiore di Sanità)

L'impegno di Farmindustria nelle malattie rare
Massimo Boriero (Presidente Gruppo Biotecnolgie-Farmindustria)

Dalla ricerca e sviluppo all'accesso: il ruolo dell'Industria
Francesca Caprari (Gruppo Farmaco Assobiotec)

Empowerment sociale e sostenibilità
Renza Barbon Galluppi (Presidente UNIAMO)

Le malattie rare nel progetto 2015 nuove tecnologie per la vita
Emilio Platè (Membro del team di progetto 2015)

Discussion

Argento Conference Room - pav. 18 - The session is sponsored by Assogenerici - The session will be held in Italian
3.30pm - 5.00pm Biosimilars: a viable market

Chair: prof. Leonardo Santi (National Committee for Biosafety and Biotechnology)

Chairman's address

Biosimilars: from European Guidelines to management
Francesca Ravaioli (EWP EMEA - AIFA)

Biosimilars: Quality and sustainability
Giorgio Foresti (President Assogenerici)

Perspectives for biological drugs
Adriana Maggi (Director CEND - Center of Excellence on Neurodegenerative Diseases)

Biosimilars: challenges and opportunities
Roberto Gradnik (President Assobiotec)

The evaluation and the choice of a biosimilar drug in a public hospital based on safety, efficacy, effectiveness and cost-effectiveness by a combined analisys
Claudio Pisanelli (Clinical Pharmacologist)

Biosimilars, the industry's position
Massimo Di Martino ( Vice President Biotechnologies' Group Farmindustria)

Discussion

Platino Conference Room , pav. 18
3.00pm - 4.30pm Emerging technologies enabling faster development of biopharmaceuticals

Chair: Paolo Barbanti (Pharma & Biotech Advisors)

NiKem Research: a CRO focused on emerging technologies and quality in ADMET & PK
Giulio Massimo Dondio (NiKem Research)

High-potency API manufacturing by Sochinaz
Stanislas Veuthey (Sochinaz)

Trifunctional antibodies - exposing cancer to the power of immune response
Michael Jaeger (TRION Pharma)

Vitrology, a GMP BioSafety Quality Control sub-contractors for biotech drugs - Company history, overview & key factors of success
Philippe Grimm (Vitrology)

Assign Group - your experienced CRO partner in biotech clinical research
Katia Mazalin (Assign Clinical Research)

Discussion

Argento Conference Room, pav. 18
10.00am - 11.20am New frontiers of cancer targeted therapies

Chair: Marco Pierotti (Foundation IRCCS - Istituto Nazionale Tumori)

Chairman's address

Targeted Immunity for the treatment of cancer
Alcide Barberis (Head of Research and Collaborations, Telormedix)

Development of Personalized Treatments for Cancer at AstraZeneca
Davide Meani (Specialty Medical Affairs Manager, AstraZeneca)

Regulation of self-renewal in Cancer Stem Cells
Pier Giuseppe Pelicci (European Institute of Oncology)

A translational medicine approach for the development of novel VEGF/FGF inhibitor E-3810
Maria Gabriella Camboni (EOS)

Discussion

Organized in co-operation with NFI - Nutrition Foundation of Italy, Platino Conference Room, pav. 18
10.00am - 11.10am Nutraceuticals and functional foods

Chair: Rodolfo Paoletti (President NFI)
Claudio Galli (Faculty of Pharmacy, University of Milan)

Chairman's address

OMEGA 3 bioavailability: role of matrix, gender and metabolism
Claudio Galli (Faculty of Pharmacy, University of Milan)

Coffee. A multi-functional ingredient food
Roberto Menta (Ferrero)

Green tea as functional food: focus on weight control
Francesco Visioli (Micronutrients and Cardiovascular Disease Unit, University Pierre et Marie Curie, Paris)

Discussion

Argento Conference Room, pav. 18
11.30am - 1.00pm Stem cell therapies and regenerative medicine

Chairs: Marco Klinger (University of Milan, Department of Plastic Surgery - IRCCS Istituto Clinico Humanitas)
Mario Marazzi (Responsible S.S. Tissue Therapy A.O. Ospedale Niguarda Ca 'Granda)

Chairmen's address

Regenerative properties of autologous fat graft: from aesthetic to reconstructive surgery
Marco Klinger (University of Milan, Department of Plastic Surgery - IRCCS Istituto Clinico Humanitas)

Corneal epithelium: 10 years of translational medicine
Graziella Pellegrini (Coordinator of Cell Therapy Division, Center of Regenerative Medicine "Stefano Ferrari")

The use of neural stem cells for regenerating the nervous system
Gianvito Martino (Director Division of Neuroscience - San Raffaele Scientific Institute)

Cell therapy for muscular dystrophy
Giulio Cossu (Division of Regenerative Medicine - San Raffaele Scientific Institute)

Stem cells and skin repair
Francesca Crovato (Tissue Therapy A.O. Ospedale Niguarda Ca 'Granda)

Quality requirements in stem cells production
Fabio Geremia (Pharmaceutical Consultant CTP System)

Discussion

Platino Conference Room, pav. 18 - Organized in co-operation with PROMOS and Regione Lombardia
11.10am - 12.50am Investing in innovation. The optimal path from initial idea to business start-up

Chair: Anna Gervasoni (Executive Director AIFI)

Chairman's address

Ernst & Young's Global Biotechnology Report 2009
Fabrizio Perrone (Executive Director Ernst & Young)

The role of the European Patent Office in supporting innovation
Enrique Molina Galan (Director Directorate Biotechnology, European Patent Office)

Financing innovation: the Lombardy Region approach
AlbertoTrombetta (Head of Venture Capital, Finlombarda gestioni SGR)

The role of venture capital
Marco Boorsma (Senior Analyst - Forbion Capital Partners)
Kreske Nickelsen (Investment Partner-Aescap Venture)
Matthias Fehr ( HBM Partners AG)
Peter Neubeck (Generale Partner, TVM Capital)
Pierluigi Paracchi (Managing Director, Quantica SGR)

Discussion

Argento Conference Room, pav. 18
2.00pm - 3.15pm Vaccines: today and tomorrow

Chair: Guido Grandi (Novartis)

Chairman's address

Marco Ercolani (Direttore Medico Prevenzione - GlaxoSmithKline)
Adjuvant Systems: the immunomodulators of the future

Vaccines for adults and the elderly
Raffaele Di Marzo (Medical & Scientific Director, Sanofi Pasteur MSD)

The development of a vaccine against the novel influenza A H1N1 pandemic virus
Giuseppe del Giudice (Global Head Translational Medicine, Novartis)

Antibody vaccine development and manufacturing
Claudio Panzarella (Menarini Biotech Business Scout)

Sensitive drug and primary container interactions
Nicolas Morais (BD Medical)

Discussion

Platino Conference Room, pav. 18
2.00 pm - 4.10 pm Roundtable: The role of Science Parks in the start-up creation and business incubation

Chair: Emil Abirascid (Chief Editor of Inn'ovazione )

Welcome introduction

AREA Science Park Trieste

Bioindustry Park del Canavese

Insubrias Biopark

Parco Tecnologico Padano

Parco Scientifico e Tecnologico della Sicilia

Sardegna Ricerche

Technapoli

Toscana Life Sciences Foundation

Argento Conference Room, pav. 18
3.30pm - 4.45pm Diagnostics in genetic diseases and targeted drug therapy

Chair: Maurizio Ferrari (Director of Clinical Molecular Biology Lab, San Raffaele Hospital)
Arialdo Vernocchi (Director of Clinical Pathology Department, Treviglio Hospital)

Chairman's address

Pharmacogenomics: genetic variants and personalized therapies
Silvia Calatroni (Treviglio Hospital)

Loxin Test: an aid for the assesment of cardiovascular risk
Irene Predazzi (University of Rome - Tor Vergata)

The "GOLDChip" microarray in prenatal diagnosis
Giusy Stoico (Molecular Genetics Division, Technogenetics)

Rapidity and highthroughput in the prenatal diagnosis of the most common chromosomal aneuploidies
Enrico Bartolini (Molecular Genetics Division, Technogenetics)

Discussion

Argento Conference Room, pav. 18 - Session sponsored by EON Medica, IGEA, AT Grade and MIDA Tecnologia Medica
10.00am - 12.10am Cartilage regeneration: today, tomorrow and beyond

Chairs: Dario Capitani (A.O. Ospedale Niguarda Ca' Granda)
Enzo Marinoni (A.O. Ospedale Niguarda Ca' Granda)
Riccardo Minola (Milano)

Cartilage Regeneration: state of the art
Enzo Marinoni (A.O. Ospedale Niguarda Ca' Granda)

Basic science in "one step" and "two steps" cartilage regeneration techniques
Giuseppe Peretti (Facoltà di Scienze Motorie, Università degli Studi di Milano)

Autologous Chondrocyte Transplantation 10 years later: where are we?
Massimo Berruto (Hospital G. Pini, Milan)

Autologus condricytes implantation on scaffolds: concepts and clinical results
Marco Bigoni (Università degli Studi di Milano Bicocca)

Smart biomimetic scaffolds in the osteochondral tissue regeneration
Daniele Pressato (Director Research and Development Finceramica)

Treatment of condral defects with collagen membrane and mesenchymal stem cells
Piero Volpi (I.R.C.C.S. Istituto Ortopedico Galeazzi)

Cartilage regeneration and electrical stimulation
Ruggero Cadossi (Igea, Carpi)

A new technology in cartilage tissue regeneration
Alfredo Franceschini (A T Grade)

Discussion

Platino Conference Room, pav. 18
10.00 am - 12.50 am Transnational research in the biotech field: opportunities for start-ups in Europe

Chair: Fabrizio Conicella (Bioindustry Park del Canavese)

Chairman's address

The value of transnational research for the young biotech companies
Fabrizio Conicella (Bioindustry Park del Canavese)

EUROTRANS-BIO experience in promoting transnational R&D projects: results and perspectives
Valentina Milazzo, (Institute for Industrial Promotion)

The European Innovative Medicines Initiative (IMI): challenges and opportunities
Giovina Ruberti (Institute of Cell Biology, National Research Council, Italian representative in IMI)

A first case of a company involved into a transnational R&D project
Fabio Bianco (Neuro-zone)

A second case of a company involved into a transnational R&D project
Paolo Gasco (Nanovector)
Carla Caccia (Newron)

Discussion

Workshop
Technology transfer: breaking the barriers for improving academia to industry collaboration
Chair: Daniela Bellomo (Director Office of Biotechnology Transfer San Raffaele Scientific Institute - Italy)

Mordechay Sheves (Vice President for Technology Transfer Weizmann Institute of Science)

Giampiero de Luca (Vice President Intellectual Property and Licensing-Merck Serono - Geneva - Switzerland)

Giuseppe Martini (Director Department of Life Science - CNR - Italy)

Riccardo Pietrabissa (President Netval and Pro Rettore Vicario (Lecco) Politecnico di Milano - Italy)

Dario Neri (ETH Professor and Co-Founder, Scientific Director Philogen SpA - Italy)